Cardiology

Blood pressure check
Health

Patients whose blood pressure only spikes at the doctor’s office are twice as likely to die of a heart attack or other cardiac event

By Ruth Hailu

Football 1961
Health

Former NFL players die at a faster rate than other professional athletes, study finds

By Shraddha Chakradhar

Adam's Take

Fibrogen’s obtuse disclosures about anemia pill raise concerns over heart safety, putting approval at risk

By Adam Feuerstein

Play
The Readout LOUD

Listen: Pharma felonies, cardiac CRISPR, and a strange day at the FDA

By Damian Garde and Adam Feuerstein

Sekar Kathiresan, Verve CEO
Biotech

With a superstar cardiologist as its CEO, new CRISPR company targets heart disease

By Sharon Begley

Current device
Health

A machine learning device, meant to monitor the chronically ill, moves into homes

By Casey Ross

High Blood Pressure
Health

For its next phase, the Framingham Heart Study will explore the biology of aging

By Robert Weisman — Boston Globe

Peter Bucciarelli
Health

Hepatitis C-infected hearts and lungs can be safely transplanted, study says, opening way to more donors

By Jacquelyn Corley

Lipitor
First Opinion

Preventing heart disease requires more than medicine

By Robert M. Kaplan

Amarin Transcript
Hospitals

CMS proposes changing requirements for less-invasive heart valve procedure

By Matthew Herper

Easier Heart Valves
Business

The astounding 19-year journey to a sea change for heart patients

By Matthew Herper

Vascepa pill handout
Health

Amarin’s Vascepa prevents second and third heart attacks in analysis, fueling debate

By Matthew Herper

Clogged Artery
Biotech

New results show benefits of Esperion’s cholesterol drug — but leave big questions unanswered

By Matthew Herper

Red blood cells
Biotech

Tiny PhaseBio gets the New England Journal’s spotlight. Can its shares rebound?

By Matthew Herper

Health

Next for Apple Watch: a ‘pragmatic’ clinical trial with J&J to track heart health

By Matthew Herper

Apple Watch 4
Health

Giant study shows Apple Watch can spot heart rhythm changes — but it’s far from ‘medical-grade technology’

By Matthew Herper

Apple health watch
First Opinion

Beware the hype over the Apple Watch heart app. The device could do more harm than good

By Larry Husten

New apple watch
Health

At a big cardiology meeting, glitzy tech will collide with sober science

By Matthew Herper

Cholesterol blood test
Biotech

Regeneron and Sanofi cut Praluent price 60 percent, as low-selling cholesterol drugs become a drug pricing laboratory

By Matthew Herper

Apple Watch
First Opinion

The Apple Watch 4 is an iffy atrial fibrillation detector in those under age 55

By Daniel Yazdi

Health

At glitzy Vegas tech show, chronic-disease gadgets to take center stage

By Casey Ross

Lifesaver ocean
Biotech

Can precision medicine rescue a multibillion-dollar pharma debacle?

By Damian Garde

DNA Test
Health

What’s a polygenic risk score and how good is it at predicting disease?

By Rebecca Robbins, Damian Garde, and Adam Feuerstein

China Gene Edited Babies
Exclusive

‘CRISPR babies’ lab asked U.S. scientist for help to disable cholesterol gene in human embryos

By Sharon Begley

Arena Pharmaceuticals
Biotech

United Therapeutics licenses Arena hypertension drug in a deal worth up to $1.2 billion

By Kate Sheridan

MORE Red Blood Cells
In the Lab

Generic arthritis drug comes up short against inflammation in heart disease

By Elizabeth Cooney

Electrocardiogram readout
Health

Low income explains poorer survival after a heart attack more than race, study finds

By Elizabeth Cooney

echocardiogram
In the Lab

Heart failure study paused over concerns about disputed cell therapy papers

By Elizabeth Cooney

Anatomical heart
Biotech

A new drug lowers cholesterol. Can it spoil a multibillion-dollar market?

By Damian Garde

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy